ArticleInfectious diseases and therapy2022

Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.

Ramón Teira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.